The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway

10.1073/pnas.1018859108

Saved in:
Bibliographic Details
Main Authors: Jin, K., Kong, X., Shah, T., Penet, M.-F., Wildes, F., Sgroi, D.C., Ma, X.-J., Huang, Y., Kallioniemi, A., Landberg, G., Bieche, I., Wu, X., Lobie, P.E., Davidson, N.E., Bhujwalla, Z.M., Zhu, T., Sukumar, S.
Other Authors: PHARMACOLOGY
Format: Article
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/108572
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-108572
record_format dspace
spelling sg-nus-scholar.10635-1085722023-10-30T08:03:31Z The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway Jin, K. Kong, X. Shah, T. Penet, M.-F. Wildes, F. Sgroi, D.C. Ma, X.-J. Huang, Y. Kallioniemi, A. Landberg, G. Bieche, I. Wu, X. Lobie, P.E. Davidson, N.E. Bhujwalla, Z.M. Zhu, T. Sukumar, S. PHARMACOLOGY 10.1073/pnas.1018859108 Proceedings of the National Academy of Sciences of the United States of America 109 8 2736-2741 PNASA 2014-11-25T09:47:44Z 2014-11-25T09:47:44Z 2012-02-21 Article Jin, K., Kong, X., Shah, T., Penet, M.-F., Wildes, F., Sgroi, D.C., Ma, X.-J., Huang, Y., Kallioniemi, A., Landberg, G., Bieche, I., Wu, X., Lobie, P.E., Davidson, N.E., Bhujwalla, Z.M., Zhu, T., Sukumar, S. (2012-02-21). The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proceedings of the National Academy of Sciences of the United States of America 109 (8) : 2736-2741. ScholarBank@NUS Repository. https://doi.org/10.1073/pnas.1018859108 00278424 http://scholarbank.nus.edu.sg/handle/10635/108572 000300495100022 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1073/pnas.1018859108
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Jin, K.
Kong, X.
Shah, T.
Penet, M.-F.
Wildes, F.
Sgroi, D.C.
Ma, X.-J.
Huang, Y.
Kallioniemi, A.
Landberg, G.
Bieche, I.
Wu, X.
Lobie, P.E.
Davidson, N.E.
Bhujwalla, Z.M.
Zhu, T.
Sukumar, S.
format Article
author Jin, K.
Kong, X.
Shah, T.
Penet, M.-F.
Wildes, F.
Sgroi, D.C.
Ma, X.-J.
Huang, Y.
Kallioniemi, A.
Landberg, G.
Bieche, I.
Wu, X.
Lobie, P.E.
Davidson, N.E.
Bhujwalla, Z.M.
Zhu, T.
Sukumar, S.
spellingShingle Jin, K.
Kong, X.
Shah, T.
Penet, M.-F.
Wildes, F.
Sgroi, D.C.
Ma, X.-J.
Huang, Y.
Kallioniemi, A.
Landberg, G.
Bieche, I.
Wu, X.
Lobie, P.E.
Davidson, N.E.
Bhujwalla, Z.M.
Zhu, T.
Sukumar, S.
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
author_sort Jin, K.
title The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
title_short The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
title_full The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
title_fullStr The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
title_full_unstemmed The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
title_sort hoxb7 protein renders breast cancer cells resistant to tamoxifen through activation of the egfr pathway
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/108572
_version_ 1781788539717943296